Target, CVS and Walgreens have all been limiting purchases of baby formula amid a nationwide shortage.

ShockWave among companies seen in play as Real Money's Kevin Curran runs down the factors driving mergers and acquisitions in the health industry.

The at-home Covid tests are seen as essential to getting the pandemic under control. But they're tough to get and now are more costly.

Looking for growth prospects as CES 2022 kicks off? Let the rollout of 5G be your roadmap.

Despite the pandemic, supply-chain woes and rising inflation, things still went right last year for many smart investors.

Stock futures were mixed as omicron cases dominate the U.S. covid surge.

Cases of coronavirus in the U.S. have spiked over the past week, with New York reporting more than 20,000 new cases a day for three days in a row.

Jim Cramer says market sentiment may be fickle, but it also can be a powerful driver of buying opportunities for investors who do their homework.

Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.

People who are traveling by air are about to see a change in recent trends.

Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.

You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.